Interview with Fabian Dwyer, General Manager, IMS Health Australia
How have your experiences at Quintiles, Astra, Baxter, and Innovex – covering the spectrum from small to large pharma in addition to the service side – helped in managing IMS…
Address: Suite 406, Kew Junction Tower, 89 High Street Kew, Vic 3101,Australia
Tel: +61 3 9455 1444
Web: http://www.imshealth.com.au/
With offices in Sydney, Melbourne and Auckland, IMS Health Australia is a trusted partner delivering solutions to local pharmaceutical and healthcare sectors.
IMS Health Australia captures information from a wide range of sources including pharmacies, hospitals, pharmaceutical wholesales, healthcare professionals, software suppliers and the pharmaceutical industry. This information is combined to give a complete picture of the market and is critical in business decisions such as assessing the impact of product launches or identifying new uses for existing therapies.
IMS Health Australia provides crucial insight into the pharmaceutical industry, healthcare manufacturers, distributors, government and healthcare agencies, academic institutions and research organizations. This information enables the development of medical education and information programs, rationale of the cost-effectiveness of drug therapies and evaluation of patient health outcomes in health policy decisions. This information is critical to both IMS Health Australia’s customers and supply partners and provides a clearer picture of the healthcare landscape.
IMS Health Australia is committed to servicing the information needs of the healthcare sector. IMS Health Australia offers a continuum of capabilities from information to analytics to consulting. With over 50 years experience and offices in more than 100 countries, IMS Health Australia is the leading source of global information for the pharmaceutical and healthcare industry.
Analytics, Research and development, Generics, Consulting
How have your experiences at Quintiles, Astra, Baxter, and Innovex – covering the spectrum from small to large pharma in addition to the service side – helped in managing IMS…
Pharmaceutical policy issues played a major role in Australia’s recent national election. Shawview Consulting’s Brendan Shaw outlines the medicines issues that came under scrutiny during the campaign. It was the…
Writing in April edition of DIA’s Global Forum magazine, the University of New South Wales’s Richard Day looks at Australia’s National Medicines Policy (NMP) and how it is being reshaped…
Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health, Melbourne and St. Vincent’s Hospital Sydney outline how…
In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association (APPA) Past President David Grolman highlights the contributions that Australia is already…
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the COVID-19 pandemic, providing opportunities for the life…
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of New South Wales, Medicine, St. Vincent’s Hospital) and John Skeritt, Head of Australia’s Therapeutic Goods Administration (TGA),…
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices is beneficial to patients, companies and healthcare systems as a whole. Goodwin also gives his five…
Can you start by giving our readers a brief overview of the company’s history here and your most notable achievements? Initially the company was founded as a small distributor of…
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important division of the Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent milestones & achievements and the current focus areas of its research activities? Broadly speaking,…
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT…
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in 2011. Can you please begin with giving our readers an introduction to…
See our Cookie Privacy Policy Here
